Programmed Death of T Cells in the Course of HIV Infection View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1995

AUTHORS

Linde Meyaard , Frank Miedema

ABSTRACT

Infection with the human immunodeficiency virus (HIV) is characterized by an asymptomatic phase of variable length and a decline in CD4+ T-cell numbers, eventually leading to the acquired immune deficiency syndrome (AIDS). Importantly, even before CD4+ T-cell numbers start to decline, functional abnormalities of T cells can be demonstrated in asymptomatically infected individuals. Both CD4+ and CD8+ T-cell function such as IL-2 production and proliferation in response to recall antigens and CD3 antibodies is affected (Shearer et al.1984; Miedema et al.1988; Schellekens et al.1990). One of the enigmas of AIDS pathogenesis is the mechanism by which HIV is capable of perturbing immune functions in a stage of infection where the number of infected cells is low (Schnittman et al.1989). In the past few years, several possible mechanisms have been investigated, including specific loss of memory cells, induction of anergy by antigen presenting cell dysfunction or dysregulation of the Thl/Th2 cytokine balance (reviewed in (Miedema et al.1994)). Following the hypothesis by Ameisen et al (Ameisen et al.1991), who proposed apoptosis as a mechanism for CD4+ T-cell depletion and loss of cellular immune function, several groups, including our group, have investigated PCD of (CD4+) T cells as a possible cause of T-cell dysfunction and CD4+ T-cell depletion in HIV-infected individuals. More... »

PAGES

115-120

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10

DOI

http://dx.doi.org/10.1007/978-1-4615-1995-9_10

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039099058

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7572385


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD4-Positive T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.417732.4", 
          "name": [
            "Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meyaard", 
        "givenName": "Linde", 
        "id": "sg:person.01321204566.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321204566.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.7177.6", 
          "name": [
            "Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miedema", 
        "givenName": "Frank", 
        "id": "sg:person.012755664317.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012755664317.02"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1995", 
    "datePublishedReg": "1995-01-01", 
    "description": "Infection with the human immunodeficiency virus (HIV) is characterized by an asymptomatic phase of variable length and a decline in CD4+ T-cell numbers, eventually leading to the acquired immune deficiency syndrome (AIDS). Importantly, even before CD4+ T-cell numbers start to decline, functional abnormalities of T cells can be demonstrated in asymptomatically infected individuals. Both CD4+ and CD8+ T-cell function such as IL-2 production and proliferation in response to recall antigens and CD3 antibodies is affected (Shearer et al.1984; Miedema et al.1988; Schellekens et al.1990). One of the enigmas of AIDS pathogenesis is the mechanism by which HIV is capable of perturbing immune functions in a stage of infection where the number of infected cells is low (Schnittman et al.1989). In the past few years, several possible mechanisms have been investigated, including specific loss of memory cells, induction of anergy by antigen presenting cell dysfunction or dysregulation of the Thl/Th2 cytokine balance (reviewed in (Miedema et al.1994)). Following the hypothesis by Ameisen et al (Ameisen et al.1991), who proposed apoptosis as a mechanism for CD4+ T-cell depletion and loss of cellular immune function, several groups, including our group, have investigated PCD of (CD4+) T cells as a possible cause of T-cell dysfunction and CD4+ T-cell depletion in HIV-infected individuals.", 
    "editor": [
      {
        "familyName": "Andrieu", 
        "givenName": "Jean-Marie", 
        "type": "Person"
      }, 
      {
        "familyName": "Lu", 
        "givenName": "Wei", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4615-1995-9_10", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4613-5823-7", 
        "978-1-4615-1995-9"
      ], 
      "name": "Cell Activation and Apoptosis in HIV Infection", 
      "type": "Book"
    }, 
    "keywords": [
      "human immunodeficiency virus", 
      "T cell numbers", 
      "T-cell depletion", 
      "T cells", 
      "immune function", 
      "cellular immune function", 
      "Th2 cytokine balance", 
      "T cell dysfunction", 
      "immune deficiency syndrome", 
      "T cell function", 
      "induction of anergy", 
      "IL-2 production", 
      "stage of infection", 
      "cytokine balance", 
      "HIV infection", 
      "immunodeficiency virus", 
      "asymptomatic phase", 
      "AIDS pathogenesis", 
      "deficiency syndrome", 
      "functional abnormalities", 
      "CD3 antibody", 
      "cell dysfunction", 
      "CD4", 
      "infection", 
      "infected cells", 
      "dysfunction", 
      "antigen", 
      "cells", 
      "specific loss", 
      "possible causes", 
      "possible mechanism", 
      "CD8", 
      "anergy", 
      "group", 
      "syndrome", 
      "pathogenesis", 
      "abnormalities", 
      "individuals", 
      "antibodies", 
      "dysregulation", 
      "memory cells", 
      "death", 
      "depletion", 
      "virus", 
      "apoptosis", 
      "proliferation", 
      "cause", 
      "induction", 
      "mechanism", 
      "loss", 
      "function", 
      "years", 
      "course", 
      "response", 
      "number", 
      "decline", 
      "enigma", 
      "hypothesis", 
      "stage", 
      "balance", 
      "length", 
      "variable length", 
      "production", 
      "PCD", 
      "et al", 
      "phase", 
      "al"
    ], 
    "name": "Programmed Death of T Cells in the Course of HIV Infection", 
    "pagination": "115-120", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039099058"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4615-1995-9_10"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7572385"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4615-1995-9_10", 
      "https://app.dimensions.ai/details/publication/pub.1039099058"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_192.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4615-1995-9_10"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'


 

This table displays all metadata directly associated to this object as RDF triples.

169 TRIPLES      22 PREDICATES      99 URIs      92 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4615-1995-9_10 schema:about N1f97400ba2b04ac79cc3a1118982e787
2 N3e246d19d56441d194fb4a9739bed690
3 N92795616ac4242698ea21f17f8be3ae3
4 Ne097c81908514214ac569c29da2998c2
5 Nf42c07969f4c4b3a81f5868f0ec719e0
6 Nf5fc3b4db3f0471f87e3aa31c72febe8
7 anzsrc-for:11
8 anzsrc-for:1107
9 schema:author Nfe11d87f65ef42ed8bacfbd4b929ce02
10 schema:datePublished 1995
11 schema:datePublishedReg 1995-01-01
12 schema:description Infection with the human immunodeficiency virus (HIV) is characterized by an asymptomatic phase of variable length and a decline in CD4+ T-cell numbers, eventually leading to the acquired immune deficiency syndrome (AIDS). Importantly, even before CD4+ T-cell numbers start to decline, functional abnormalities of T cells can be demonstrated in asymptomatically infected individuals. Both CD4+ and CD8+ T-cell function such as IL-2 production and proliferation in response to recall antigens and CD3 antibodies is affected (Shearer et al.1984; Miedema et al.1988; Schellekens et al.1990). One of the enigmas of AIDS pathogenesis is the mechanism by which HIV is capable of perturbing immune functions in a stage of infection where the number of infected cells is low (Schnittman et al.1989). In the past few years, several possible mechanisms have been investigated, including specific loss of memory cells, induction of anergy by antigen presenting cell dysfunction or dysregulation of the Thl/Th2 cytokine balance (reviewed in (Miedema et al.1994)). Following the hypothesis by Ameisen et al (Ameisen et al.1991), who proposed apoptosis as a mechanism for CD4+ T-cell depletion and loss of cellular immune function, several groups, including our group, have investigated PCD of (CD4+) T cells as a possible cause of T-cell dysfunction and CD4+ T-cell depletion in HIV-infected individuals.
13 schema:editor Ne56360ba71bb4d5c995a017e1a6b530e
14 schema:genre chapter
15 schema:isAccessibleForFree false
16 schema:isPartOf Nb917696e6c6f477db121409314216f82
17 schema:keywords AIDS pathogenesis
18 CD3 antibody
19 CD4
20 CD8
21 HIV infection
22 IL-2 production
23 PCD
24 T cell dysfunction
25 T cell function
26 T cell numbers
27 T cells
28 T-cell depletion
29 Th2 cytokine balance
30 abnormalities
31 al
32 anergy
33 antibodies
34 antigen
35 apoptosis
36 asymptomatic phase
37 balance
38 cause
39 cell dysfunction
40 cells
41 cellular immune function
42 course
43 cytokine balance
44 death
45 decline
46 deficiency syndrome
47 depletion
48 dysfunction
49 dysregulation
50 enigma
51 et al
52 function
53 functional abnormalities
54 group
55 human immunodeficiency virus
56 hypothesis
57 immune deficiency syndrome
58 immune function
59 immunodeficiency virus
60 individuals
61 induction
62 induction of anergy
63 infected cells
64 infection
65 length
66 loss
67 mechanism
68 memory cells
69 number
70 pathogenesis
71 phase
72 possible causes
73 possible mechanism
74 production
75 proliferation
76 response
77 specific loss
78 stage
79 stage of infection
80 syndrome
81 variable length
82 virus
83 years
84 schema:name Programmed Death of T Cells in the Course of HIV Infection
85 schema:pagination 115-120
86 schema:productId N7f9eca16f9d5406385b605ed586a6145
87 Naa5e748c4d584ae88b58912c654acc52
88 Nd325930438f74019b5c1e140fdcdb97b
89 schema:publisher Nb58b49fc0bb34af9a52943ed78fc5360
90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039099058
91 https://doi.org/10.1007/978-1-4615-1995-9_10
92 schema:sdDatePublished 2022-09-02T16:11
93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
94 schema:sdPublisher N2ddaeae08ccd4529bc3de2317ee71697
95 schema:url https://doi.org/10.1007/978-1-4615-1995-9_10
96 sgo:license sg:explorer/license/
97 sgo:sdDataset chapters
98 rdf:type schema:Chapter
99 N12f0098c998e491fb4c3c7bebd79bb97 schema:familyName Lu
100 schema:givenName Wei
101 rdf:type schema:Person
102 N1631fdb882b647d19bfcd593ba3163c3 rdf:first N12f0098c998e491fb4c3c7bebd79bb97
103 rdf:rest rdf:nil
104 N1f97400ba2b04ac79cc3a1118982e787 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Apoptosis
106 rdf:type schema:DefinedTerm
107 N2ddaeae08ccd4529bc3de2317ee71697 schema:name Springer Nature - SN SciGraph project
108 rdf:type schema:Organization
109 N3393ae32e9c94d8ba805358be75a69b4 schema:familyName Andrieu
110 schema:givenName Jean-Marie
111 rdf:type schema:Person
112 N3e246d19d56441d194fb4a9739bed690 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Humans
114 rdf:type schema:DefinedTerm
115 N7f9eca16f9d5406385b605ed586a6145 schema:name pubmed_id
116 schema:value 7572385
117 rdf:type schema:PropertyValue
118 N92795616ac4242698ea21f17f8be3ae3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Lymphocyte Activation
120 rdf:type schema:DefinedTerm
121 Na58c5bb643c44169a2dcf2ba7e019487 rdf:first sg:person.012755664317.02
122 rdf:rest rdf:nil
123 Naa5e748c4d584ae88b58912c654acc52 schema:name doi
124 schema:value 10.1007/978-1-4615-1995-9_10
125 rdf:type schema:PropertyValue
126 Nb58b49fc0bb34af9a52943ed78fc5360 schema:name Springer Nature
127 rdf:type schema:Organisation
128 Nb917696e6c6f477db121409314216f82 schema:isbn 978-1-4613-5823-7
129 978-1-4615-1995-9
130 schema:name Cell Activation and Apoptosis in HIV Infection
131 rdf:type schema:Book
132 Nd325930438f74019b5c1e140fdcdb97b schema:name dimensions_id
133 schema:value pub.1039099058
134 rdf:type schema:PropertyValue
135 Ne097c81908514214ac569c29da2998c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Animals
137 rdf:type schema:DefinedTerm
138 Ne56360ba71bb4d5c995a017e1a6b530e rdf:first N3393ae32e9c94d8ba805358be75a69b4
139 rdf:rest N1631fdb882b647d19bfcd593ba3163c3
140 Nf42c07969f4c4b3a81f5868f0ec719e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name HIV Infections
142 rdf:type schema:DefinedTerm
143 Nf5fc3b4db3f0471f87e3aa31c72febe8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name CD4-Positive T-Lymphocytes
145 rdf:type schema:DefinedTerm
146 Nfe11d87f65ef42ed8bacfbd4b929ce02 rdf:first sg:person.01321204566.43
147 rdf:rest Na58c5bb643c44169a2dcf2ba7e019487
148 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
149 schema:name Medical and Health Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
152 schema:name Immunology
153 rdf:type schema:DefinedTerm
154 sg:person.012755664317.02 schema:affiliation grid-institutes:grid.7177.6
155 schema:familyName Miedema
156 schema:givenName Frank
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012755664317.02
158 rdf:type schema:Person
159 sg:person.01321204566.43 schema:affiliation grid-institutes:grid.417732.4
160 schema:familyName Meyaard
161 schema:givenName Linde
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321204566.43
163 rdf:type schema:Person
164 grid-institutes:grid.417732.4 schema:alternateName Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
165 schema:name Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
166 rdf:type schema:Organization
167 grid-institutes:grid.7177.6 schema:alternateName Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
168 schema:name Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
169 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...